Liang Li
- Cancer Research top 0.2%
- MicroRNA in disease regulation 35
- Cancer-related molecular mechanisms research 30
- Cancer, Hypoxia, and Metabolism 15
- Molecular Biology top 1%
- Extracellular vesicles in disease 31
- Circular RNAs in diseases 20
- RNA modifications and cancer 18
- RNA Research and Splicing 9
- Biochemistry top 1%
- Oncology top 5%
- Cancer Cells and Metastasis 10
- Co-authors
- Yanqing DingXiao-Liang LanWenting LiaoXiaoli RenFuyao SongZhicheng ZengZhao‐Chong ZengWenjie Liao
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Liang Li
185 papers receiving 6.4k citations
Hit Papers
Peers
Comparison fields: 5 of 149
- Cancer Research 3.0k
- Molecular Biology 4.3k
- Biochemistry 321
- Critical Care and Intensive Care Medicine 196
- Oncology 932
Countries citing papers authored by Liang Li
This map shows the geographic impact of Liang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liang Li more than expected).
Fields of papers citing papers by Liang Li
This network shows the impact of papers produced by Liang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liang Li. The network helps show where Liang Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Liang Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 5 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 2 | |
| 8 | 2024 | 25 | |
| 9 | 2024 | 9 | |
| 10 | 2022 | 54 | |
| 11 | 2021 | 38 | |
| 12 | 2021 | 18 | |
| 13 | 2021 | 44 | |
| 14 | 2018 | 0 | |
| 15 | 2017 | 30 | |
| 16 | 2016 | 59 | |
| 17 | MRI for assessment of axillary lymph node status in breast cancer:A Meta analysis | 2015 | 1 |
| 18 | [Population pharmacokinetics of vancomycin and prediction of pharmacodynamics in the Chinese people]. | 2014 | 9 |
| 19 | 2012 | 106 | |
| 20 | 2011 | 13 |
About Liang Li
Liang Li is a scholar working on Cancer Research, Molecular Biology and Oncology, having authored 201 papers that have together received 6.5k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (35 papers), Extracellular vesicles in disease (31 papers), Cancer-related molecular mechanisms research (30 papers), Circular RNAs in diseases (20 papers), RNA modifications and cancer (18 papers), Cancer, Hypoxia, and Metabolism (15 papers), Cancer Cells and Metastasis (10 papers) and RNA Research and Splicing (9 papers). The work is most often cited by research in Cancer Research (3.0k citations), Molecular Biology (4.3k citations) and Biochemistry (321 citations). Liang Li has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Yanqing Ding, Xiao-Liang Lan, Wenting Liao, Xiaoli Ren, Fuyao Song, Zhicheng Zeng, Zhao‐Chong Zeng, Wenjie Liao, Feifei Wang and Yuling Li. Their work appears in journals such as Oncotarget, Oncogene, PLoS ONE, Cancer Letters and Frontiers in Cell and Developmental Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.